Cargando…
69: COMPARING THE OUTCOMES OF GIVING TOCILIZUMAB THEN HEMOPERFUSION, HEMOPERFUSION THEN TOCILIZUMAB, AND NO INTERVENTION IN CRITICAL SARS-COV-2 PNEUMONIA PATIENTS IN MAKATI MEDICAL CENTER
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762126/ http://dx.doi.org/10.1016/S2213-7165(22)00348-4 |
| _version_ | 1784852806049464320 |
|---|---|
| author | Macatangay, M.V.R. Buensalido, J.A. |
| author_facet | Macatangay, M.V.R. Buensalido, J.A. |
| author_sort | Macatangay, M.V.R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9762126 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97621262022-12-19 69: COMPARING THE OUTCOMES OF GIVING TOCILIZUMAB THEN HEMOPERFUSION, HEMOPERFUSION THEN TOCILIZUMAB, AND NO INTERVENTION IN CRITICAL SARS-COV-2 PNEUMONIA PATIENTS IN MAKATI MEDICAL CENTER Macatangay, M.V.R. Buensalido, J.A. J Glob Antimicrob Resist Poster Session 2 Elsevier Ltd. 2022-12 2022-12-19 /pmc/articles/PMC9762126/ http://dx.doi.org/10.1016/S2213-7165(22)00348-4 Text en Copyright © 2022 Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Session 2 Macatangay, M.V.R. Buensalido, J.A. 69: COMPARING THE OUTCOMES OF GIVING TOCILIZUMAB THEN HEMOPERFUSION, HEMOPERFUSION THEN TOCILIZUMAB, AND NO INTERVENTION IN CRITICAL SARS-COV-2 PNEUMONIA PATIENTS IN MAKATI MEDICAL CENTER |
| title | 69: COMPARING THE OUTCOMES OF GIVING TOCILIZUMAB THEN HEMOPERFUSION, HEMOPERFUSION THEN TOCILIZUMAB, AND NO INTERVENTION IN CRITICAL SARS-COV-2 PNEUMONIA PATIENTS IN MAKATI MEDICAL CENTER |
| title_full | 69: COMPARING THE OUTCOMES OF GIVING TOCILIZUMAB THEN HEMOPERFUSION, HEMOPERFUSION THEN TOCILIZUMAB, AND NO INTERVENTION IN CRITICAL SARS-COV-2 PNEUMONIA PATIENTS IN MAKATI MEDICAL CENTER |
| title_fullStr | 69: COMPARING THE OUTCOMES OF GIVING TOCILIZUMAB THEN HEMOPERFUSION, HEMOPERFUSION THEN TOCILIZUMAB, AND NO INTERVENTION IN CRITICAL SARS-COV-2 PNEUMONIA PATIENTS IN MAKATI MEDICAL CENTER |
| title_full_unstemmed | 69: COMPARING THE OUTCOMES OF GIVING TOCILIZUMAB THEN HEMOPERFUSION, HEMOPERFUSION THEN TOCILIZUMAB, AND NO INTERVENTION IN CRITICAL SARS-COV-2 PNEUMONIA PATIENTS IN MAKATI MEDICAL CENTER |
| title_short | 69: COMPARING THE OUTCOMES OF GIVING TOCILIZUMAB THEN HEMOPERFUSION, HEMOPERFUSION THEN TOCILIZUMAB, AND NO INTERVENTION IN CRITICAL SARS-COV-2 PNEUMONIA PATIENTS IN MAKATI MEDICAL CENTER |
| title_sort | 69: comparing the outcomes of giving tocilizumab then hemoperfusion, hemoperfusion then tocilizumab, and no intervention in critical sars-cov-2 pneumonia patients in makati medical center |
| topic | Poster Session 2 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762126/ http://dx.doi.org/10.1016/S2213-7165(22)00348-4 |
| work_keys_str_mv | AT macatangaymvr 69comparingtheoutcomesofgivingtocilizumabthenhemoperfusionhemoperfusionthentocilizumabandnointerventionincriticalsarscov2pneumoniapatientsinmakatimedicalcenter AT buensalidoja 69comparingtheoutcomesofgivingtocilizumabthenhemoperfusionhemoperfusionthentocilizumabandnointerventionincriticalsarscov2pneumoniapatientsinmakatimedicalcenter |